SCHEMBL2682345

SCHEMBL2682345

CCc1cc(C=C2CCON(C)C2=O)cc(CC)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.58
CYP2C9 P11712 3/20 0.58
CYP3A4 P08684 3/20 0.58
SIRT1 Q96EB6 1/20 0.40
ALOX5 P09917 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
KMT2A Q03164 4/20 0.35
MAPT P10636 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MEN1 O00255 3/20 0.35
KDM4E B2RXH2 3/20 0.35
CYP2B6 P20813 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35
XBP1 P17861 1/20 0.35
MPI P34949 1/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13178556 0.89 CYP1A2 (0.46) CYP1A2CYP2C9CYP3A4SIRT1ALOX5
SCHEMBL2681962 0.80 PTGS1 (0.64) CYP1A2CYP2C9ALOX5PTGS1PTGS2
SCHEMBL8670047 0.80 CYP1A2 (0.59) CYP1A2CYP2C9CYP3A4ALOX5PTGS1
SCHEMBL8291651 0.80 PTGS1 (0.64) CYP1A2CYP2C9ALOX5PTGS1PTGS2
SCHEMBL2681961 0.80 PTGS1 (0.64) CYP1A2CYP2C9ALOX5PTGS1PTGS2
SCHEMBL8670044 0.80 CYP1A2 (0.59) CYP1A2CYP2C9CYP3A4ALOX5PTGS1
SCHEMBL6851613 0.75 CYP1A2 (1.00) CYP1A2CYP2C9CYP3A4SIRT1PTGS2
SCHEMBL6851627 0.75 CYP1A2 (1.00) CYP1A2CYP2C9CYP3A4SIRT1PTGS2
SCHEMBL6854900 0.72 CYP1A2 (0.87) CYP1A2CYP2C9CYP3A4KMT2AMAPT
SCHEMBL6851658 0.72 CYP1A2 (0.87) CYP1A2CYP2C9CYP3A4KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8669289-B2 Methods and compositions relating to hematologic malignancies THE JACKSON LABORATORY (US) 2014-03-11 US disclosed
US-8486922-B2 Composition CHEN CHIEN-HUNG (TW) 2013-07-16 US disclosed
US-20120183600-A1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS CHEN CHIEN-HUNG (US) 2012-07-19 US disclosed
US-20120114605-A1 METHODS AND COMPOSITIONS RELATING TO HEMATOLOGIC MALIGNANCIES THE JACKSON LABORATORY 2012-05-10 US disclosed
WO-2010124283-A2 METHODS AND COMPOSITIONS RELATING TO HEMATOLOGIC MALIGNANCIES THE JACKSON LABORATORY (US) 2010-10-28 WO disclosed